A Phase II Study of Perioperative S-1 Combined With Weekly Docetaxel in Patients With Locally Advanced Gastric Carcinoma: Clinical Outcomes and Clinicopathological and Pharmacogenetic Predictors for Survival

Gastric Cancer - Germany
doi 10.1007/s10120-015-0490-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2010English

Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
2006English

Survival Benefit of Neoadjuvant Chemotherapy With S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis

Annals of Surgical Oncology
OncologySurgery
2019English

Docetaxel and Cisplatin in Patients With Advanced Gastric Cancer: Results of Japanese Phase I/Ii Study

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2002English

Fludarabine Combined With Radiotherapy in Patients With Locally Advanced NSCLC Lung Carcinoma: A Phase I Study

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2012English

Multicenter Phase II Trial of Preoperative Chemoradiotherapy With S-1 for Locally Advanced Oral Squamous Cell Carcinoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin, and Daily Capecitabine in Patients With Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2005English

Docetaxel Versus Paclitaxel Combined With 5-Fu and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials

Cancer Research and Treatment
Cancer ResearchOncology
2009English

A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy